PDCD1LG2 and neoplasm: When the researchers considered a broader subset of 200 genes involved in the hypoxic response, PD‐L2 upregulation strikingly emerged as a stronger and more substantial determinant of tumor hypoxia than PD‐L1, suggesting a potential mechanistic relationship between hypoxia and PD‐L2‐mediated antitumor immune control.